Hypoxia has immunosuppressive effects within the tumour microenvironment and affects the expression of immune checkpoint molecules by activating HIF-1α, regulating glycolysis and the Ado-A2a receptor (A2aR) axis, and driving EMT [138,139]. Here, HIF1A is linked to neoplasm.